Nucleic Acids Research, 2000, Vol. 28, No. 23 4634-4641
© 2000 Oxford University Press
Cisplatin–DNA adducts inhibit translocation of the Ku subunits of DNA-PK
Department of Biochemistry and Molecular Biology, Wright State University School of Medicine, 3640 Colonel Glenn Highway, Dayton, OH 45435, USA
We have determined the effect of cisplatin–DNA damage on the ability of the DNA-dependent protein kinase (DNA-PK) to interact with duplex DNA molecules in vitro. The Ku DNA binding subunits of DNA-PK display a reduced ability to translocate on duplex DNA containing cisplatin–DNA adducts compared to control, undamaged duplex DNA. The decreased rates of translocation resulted in a decrease in the association of the p460 catalytic subunit of DNA-PK (DNA-PKcs) with the Ku–DNA complex. In addition to a decrease in DNA-PKcs association, the DNA-PKcs that is bound with Ku at a DNA end containing cisplatin–DNA adducts has a reduced catalytic rate compared to heterotrimeric DNA-PK assembled on undamaged DNA. The position of the cisplatin–DNA lesion from the terminus also effects kinase activation, with maximal inhibition occurring when the lesion is closer to the terminus. These results are consistent with a model for DNA-PK activation where the Ku dimer translocates away from the DNA terminus and facilitates the association of DNA-PKcs which interacts with both Ku and DNA resulting in kinase activation. The presence of cisplatin adducts decreases the ability to translocate away from the terminus and results in the formation of inactive kinase complexes at the DNA terminus. The results are discussed with respect to the ability of cisplatin to sensitize cells to DNA damage induced by ionizing radiation and the ability to repair DNA double-strand breaks.
* To whom correspondence should be addressed. Tel: +1 937 775 2853; Fax: +1 937 775 3730; Email: john.turchi{at}wright.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Sak, S. Grehl, M. Engelhard, A. Wierlemann, H.-P. Kaelberlah, P. Erichsen, C. Pottgen, M. Groneberg, and M. Stuschke Long-Term In vivo Effects of Cisplatin on {gamma}-H2AX Foci Signaling in Peripheral Lymphocytes of Tumor Patients After Irradiation Clin. Cancer Res., April 15, 2009; 15(8): 2927 - 2934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Pawelczak and J. J. Turchi A mechanism for DNA-PK activation requiring unique contributions from each strand of a DNA terminus and implications for microhomology-mediated nonhomologous DNA end joining Nucleic Acids Res., July 1, 2008; 36(12): 4022 - 4031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pabla, S. Huang, Q.-S. Mi, R. Daniel, and Z. Dong ATR-Chk2 Signaling in p53 Activation and DNA Damage Response during Cisplatin-induced Apoptosis J. Biol. Chem., March 7, 2008; 283(10): 6572 - 6583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Andrews, J. A. Lehman, and J. J. Turchi Kinetic Analysis of the Ku-DNA Binding Activity Reveals a Redox-dependent Alteration in Protein Structure That Stimulates Dissociation of the Ku-DNA Complex J. Biol. Chem., May 12, 2006; 281(19): 13596 - 13603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Diggle, J. Bentley, M. A. Knowles, and A. E. Kiltie Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts Nucleic Acids Res., May 4, 2005; 33(8): 2531 - 2539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Boeckman, K. S. Trego, and J. J. Turchi Cisplatin Sensitizes Cancer Cells to Ionizing Radiation via Inhibition of Nonhomologous End Joining Mol. Cancer Res., May 1, 2005; 3(5): 277 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Convery, E. K. Shin, Q. Ding, W. Wang, P. Douglas, L. S. Davis, J. A. Nickoloff, S. P. Lees-Miller, and K. Meek Inhibition of homologous recombination by variants of the catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs) PNAS, February 1, 2005; 102(5): 1345 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Pawelczak, B. J. Andrews, and J. J. Turchi Differential activation of DNA-PK based on DNA strand orientation and sequence bias Nucleic Acids Res., January 7, 2005; 33(1): 152 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Biston, A. Joubert, J.-F. Adam, H. Elleaume, S. Bohic, A.-M. Charvet, F. Esteve, N. Foray, and J. Balosso Cure of Fisher Rats Bearing Radioresistant F98 Glioma Treated with cis-Platinum and Irradiated with Monochromatic Synchrotron X-Rays Cancer Res., April 1, 2004; 64(7): 2317 - 2323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Corde, J. Balosso, H. Elleaume, M. Renier, A. Joubert, M.-C. Biston, J.-F. Adam, A.-M. Charvet, T. Brochard, J.-F. Le Bas, et al. Synchrotron Photoactivation of Cisplatin Elicits an Extra Number of DNA Breaks That Stimulate RAD51-mediated Repair Pathways Cancer Res., June 15, 2003; 63(12): 3221 - 3227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kysela, A. J. Doherty, M. Chovanec, T. Stiff, S. M. Ameer-Beg, B. Vojnovic, P.-M. Girard, and P. A. Jeggo Ku Stimulation of DNA Ligase IV-dependent Ligation Requires Inward Movement along the DNA Molecule J. Biol. Chem., June 13, 2003; 278(25): 22466 - 22474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Martensson and O. Hammarsten DNA-dependent Protein Kinase Catalytic Subunit. STRUCTURAL REQUIREMENTS FOR KINASE ACTIVATION BY DNA ENDS J. Biol. Chem., January 18, 2002; 277(4): 3020 - 3029. [Abstract] [Full Text] [PDF]
|
|